Tempest Therapeutics Announces Up to $7.5 Million Private Placement
September 11, 2026
The European Patent Office Grants Cannabics Pharmaceuticals Patent for Company’s Personalized Medicine Drug Discovery Technology
May 25, 2021
Related Post
-
-
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
September 11, 2026
-
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical’s FDA-Cleared Robotic TMS System
September 11, 2026
-
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol “EOCN” to Reflect its New Dawn Platform for GI Innovation
September 9, 2026